{"id":"tp-47315","type":"article-newspaper","title":"Emergent BioSolutions Projects 2026 Revenue of $600 Million to $645 Million","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/47315","datePublished":"2026-11-03T04:46:59.000Z","dateModified":"2026-11-03T04:46:59.000Z","language":"en","abstract":"The company raised its adjusted gross margin outlook to 45%-47% and expects adjusted EBITDA of $110 million to $140 million.","section":"Business","references":[]}